Role of chemokines and chemokine receptors in prostate cancer development and progression

Rajendra K. Singh, Akulapalli Sudhakar, Bal L. Lokeshwar

Research output: Contribution to journalReview article

34 Citations (Scopus)

Abstract

Prostate cancer (PC) is the second leading cause of cancer deaths in men in America and Western Europe. Epidemiological studies suggest that prostate cancer incidence & increased in last few years in Asia. The causes or consequences of increasing trend of prostate cancer incidence are not completely known. Emerging evidences suggest that among the many risk factors, inflammation is the major risk factor for developing prostate cancer and its progression to metastasis. It is proposed that exposure to environmental factors such as infectious agents, dietary agents and saturated lipids leads to injury of the prostate due to chronic inflammation and regenerative risk factor lesions referred to as proliferative inflammatory atrophy (PIA). These phenomena predominantly control by a number of pro-inflammatory macromolecules such as chemokines, and their receptors. Some recent studies suggest that many of these pro-inflammatory chemokines and their receptors are the products of protooncogenes in many cancers including that of the prostate. This review focus on the current biology of chemokines and chemokine receptors in prostate cancer. An understanding of this axis may enable researchers to develop targeted strategies for prostate cancer.

Original languageEnglish (US)
Pages (from-to)89-94
Number of pages6
JournalJournal of Cancer Science and Therapy
Volume2
Issue number4
DOIs
StatePublished - Aug 2 2010

Fingerprint

Chemokine Receptors
Chemokines
Prostatic Neoplasms
Inflammation
Incidence
Environmental Exposure
Atrophy
Epidemiologic Studies
Prostate
Cause of Death
Research Personnel
Neoplasm Metastasis
Lipids
Wounds and Injuries
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Role of chemokines and chemokine receptors in prostate cancer development and progression. / Singh, Rajendra K.; Sudhakar, Akulapalli; Lokeshwar, Bal L.

In: Journal of Cancer Science and Therapy, Vol. 2, No. 4, 02.08.2010, p. 89-94.

Research output: Contribution to journalReview article

@article{4ea575a070ed4817abf3683a01151975,
title = "Role of chemokines and chemokine receptors in prostate cancer development and progression",
abstract = "Prostate cancer (PC) is the second leading cause of cancer deaths in men in America and Western Europe. Epidemiological studies suggest that prostate cancer incidence & increased in last few years in Asia. The causes or consequences of increasing trend of prostate cancer incidence are not completely known. Emerging evidences suggest that among the many risk factors, inflammation is the major risk factor for developing prostate cancer and its progression to metastasis. It is proposed that exposure to environmental factors such as infectious agents, dietary agents and saturated lipids leads to injury of the prostate due to chronic inflammation and regenerative risk factor lesions referred to as proliferative inflammatory atrophy (PIA). These phenomena predominantly control by a number of pro-inflammatory macromolecules such as chemokines, and their receptors. Some recent studies suggest that many of these pro-inflammatory chemokines and their receptors are the products of protooncogenes in many cancers including that of the prostate. This review focus on the current biology of chemokines and chemokine receptors in prostate cancer. An understanding of this axis may enable researchers to develop targeted strategies for prostate cancer.",
author = "Singh, {Rajendra K.} and Akulapalli Sudhakar and Lokeshwar, {Bal L.}",
year = "2010",
month = "8",
day = "2",
doi = "10.4172/1948-5956.1000030",
language = "English (US)",
volume = "2",
pages = "89--94",
journal = "Journal of Cancer Science and Therapy",
issn = "1948-5956",
publisher = "OMICS Publishing Group",
number = "4",

}

TY - JOUR

T1 - Role of chemokines and chemokine receptors in prostate cancer development and progression

AU - Singh, Rajendra K.

AU - Sudhakar, Akulapalli

AU - Lokeshwar, Bal L.

PY - 2010/8/2

Y1 - 2010/8/2

N2 - Prostate cancer (PC) is the second leading cause of cancer deaths in men in America and Western Europe. Epidemiological studies suggest that prostate cancer incidence & increased in last few years in Asia. The causes or consequences of increasing trend of prostate cancer incidence are not completely known. Emerging evidences suggest that among the many risk factors, inflammation is the major risk factor for developing prostate cancer and its progression to metastasis. It is proposed that exposure to environmental factors such as infectious agents, dietary agents and saturated lipids leads to injury of the prostate due to chronic inflammation and regenerative risk factor lesions referred to as proliferative inflammatory atrophy (PIA). These phenomena predominantly control by a number of pro-inflammatory macromolecules such as chemokines, and their receptors. Some recent studies suggest that many of these pro-inflammatory chemokines and their receptors are the products of protooncogenes in many cancers including that of the prostate. This review focus on the current biology of chemokines and chemokine receptors in prostate cancer. An understanding of this axis may enable researchers to develop targeted strategies for prostate cancer.

AB - Prostate cancer (PC) is the second leading cause of cancer deaths in men in America and Western Europe. Epidemiological studies suggest that prostate cancer incidence & increased in last few years in Asia. The causes or consequences of increasing trend of prostate cancer incidence are not completely known. Emerging evidences suggest that among the many risk factors, inflammation is the major risk factor for developing prostate cancer and its progression to metastasis. It is proposed that exposure to environmental factors such as infectious agents, dietary agents and saturated lipids leads to injury of the prostate due to chronic inflammation and regenerative risk factor lesions referred to as proliferative inflammatory atrophy (PIA). These phenomena predominantly control by a number of pro-inflammatory macromolecules such as chemokines, and their receptors. Some recent studies suggest that many of these pro-inflammatory chemokines and their receptors are the products of protooncogenes in many cancers including that of the prostate. This review focus on the current biology of chemokines and chemokine receptors in prostate cancer. An understanding of this axis may enable researchers to develop targeted strategies for prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=77954983359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954983359&partnerID=8YFLogxK

U2 - 10.4172/1948-5956.1000030

DO - 10.4172/1948-5956.1000030

M3 - Review article

AN - SCOPUS:77954983359

VL - 2

SP - 89

EP - 94

JO - Journal of Cancer Science and Therapy

JF - Journal of Cancer Science and Therapy

SN - 1948-5956

IS - 4

ER -